CAH · 8-K · 20261001PR000041
Guidance / Outlook
CARDINAL HEALTH INC · 2026-10-01 · Importance 45 · Surprise 22 · In source text
Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, or $12.40 to $12.60 per share. The company also reaffirmed its long-term non-GAAP EPS growth guidance of 12% to 14%. Fiscal 2027 growth rates are based on adjusted fiscal 2026 results that exclude the fiscal 2026 benefit from IEEPA tariff refunds. The company said it may provide further updates on its November 5, 2026 first-quarter earnings call.
Key facts
- Cardinal Health reaffirmed fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth, or $12.40 to $12.60. source
- Cardinal Health reaffirmed long-term non-GAAP EPS growth rate guidance of 12% to 14%. source
- Cardinal Health may provide further updates during its first quarter earnings call on November 5, 2026. source
- Cardinal Health stated that fiscal year 2027 guidance growth rates are based on adjusted fiscal year 2026 results that exclude the fiscal year 2026 benefit from the IEEPA tariff refund. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | committed | — | Cardinal Health reaffirmed fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth, or $12.40 to $12.60. |
| net_income | positive | committed | — | Cardinal Health reaffirmed long-term non-GAAP EPS growth rate guidance of 12% to 14%. |